Skip to main content

ORIGINAL RESEARCH article

Front. Cardiovasc. Med.
Sec. Coronary Artery Disease
Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1500978

Efficacy and prognosis of dapagliflozin in the treatment of patients with acute myocardial infarction complicated with type 2 diabetes in Xining area

Provisionally accepted
Jinping Chai Jinping Chai Li De Lian Li De Lian *Su Xiao Ling Su Xiao Ling *Liu Yan Min Liu Yan Min *
  • Qinghai Provincial People's Hospital, Xining, China

The final, formatted version of the article will be published soon.

    The acute myocardial infarction (AMI) is a prevalent and severe cardiovascular disease, characterized by its sudden onset, high mortality rate, and unfavorable prognosis. The presence of type 2 diabetes not only signifies a chronic metabolic disorder, but also serves as a catalyst for various cardiovascular and cerebrovascular ailments such as coronary heart disease and stroke. Xining is situated in a region of middle to high altitude and due to its unique geographical environment, coupled with the population's limited health awareness, unequal medical standards and other factors, there remain some AMI patients who are difficult to diagnose early on. The objective of this study is to investigate the efficacy and prognosis of dapagliflozin in patients with acute myocardial infarction complicated by type 2 diabetes in the Xining region.

    Keywords: acute myocardial infarction, type 2 diabetes, dapagliflozin, prognosis, complications

    Received: 24 Sep 2024; Accepted: 20 Jan 2025.

    Copyright: © 2025 Chai, Lian, Ling and Min. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Li De Lian, Qinghai Provincial People's Hospital, Xining, China
    Su Xiao Ling, Qinghai Provincial People's Hospital, Xining, China
    Liu Yan Min, Qinghai Provincial People's Hospital, Xining, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.